According to the American Cancer Society, prostate cancer is the second most common type of cancer in American men (behind skin cancer), and the second-leading cause of cancer death in men (after lung cancer). In 2014, more than 230,000 new cases of prostate cancer will be diagnosed…
Robot-assisted surgery was first widely used for radical prostatectomy. For procedures such as prostatectomy, where there were previously no minimally invasive options, robot-assisted laparoscopy often offered a dramatic improvement…
A new study by researchers at The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James) shows that a molecule called nuclear factor kappa B (NF-kB) helps cancer cells by suppressing the immune system’s ability to detect and destroy them. …
In a review paper published in the October issue of Neuro-Oncology, the researchers discuss various targeted therapies against IL13Rα2 and early successes of clinical trials with these therapies in the treatment of GBM. The paper also highlights the need for future trials to improve efficacy and toxicity profiles of targeted therapies in this field. …
In an effort to solve this mystery, neuroscientists at The University of Texas Health Science Center at Houston (UTHealth) conducted an experiment in an animal memory model and their results point to a possible explanation. Findings appeared in The Journal of Neuroscience. In the study involving a sea snail that shares many of the same memory mechanisms as humans and a drug used to treat a variety of cancers, the scientists identified memory mechanisms blocked by the drug. …
The study is testing bioimpedance spectroscopy, a device where electrodes are placed on the patient’s arms so that the fluid buildup can be accurately measured. The randomized study is enrolling 1,100 research subjects over two years at five sites in the United States and Australia. “Many in the health care community, and even breast cancer patients, don’t understand that this lifelong arm swelling is a possible result of breast cancer treatment, but others of us have been working on this issue for decades,” said principal investigator Sheila H. …
The Nanoparticles by Design Unit at the Okinawa Institute of Science and Technology Graduate University is trying to develop new particles with unprecedented properties that still meet these requirements. Recently, Dr. Jeong-Hwan Kim took one step forward when he experimented with a new type of nanomaterial: the nanosheet. Specifically, he designed a strong, stable, and optically traceable smart 2-D material that responds to pH, or the acidity or basicity of its surrounding environment…
Their findings are the subject of a report, “More Skin, More Sun, More Tan, More Melanoma,” in the October 6, 2014 issue of the American Journal of Public Health. …
“Most of the time, there’s no bad news,” says Karen Rizzo, MD, 2015 president of the Pennsylvania Medical Society and a practicing physician in Lancaster. …
The research, conducted by the Medical Center’s Wake Forest Institute for Regenerative Medicine (WFIRM) under the direction of Anthony Atala, M.D., institute director, gives boys who have a high risk of becoming sterile the option to “bank” a small piece of testicular tissue prior to treatment. “The average survival rates for childhood cancer are around 80 percent, but a side effect of some treatments can be permanent sterility,” said Thomas W. McLean, M.D., a pediatric cancer specialist, who co-leads the experimental biological bank with Hooman Sadri-Ardekani, M.D., Ph.D., a male infertility specialist at WFIRM. …